4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-18-014761
Director sold 32,300 shares at an average $0.79 ($25,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MORSE DANIEL E. Director | 2018-02-22 | Sale | −7,800 | $0.78 | $6,115 | 28,866 | I |
| MORSE DANIEL E. Director | 2018-02-26 | Sale | −7,000 | $0.79 | $5,530 | 21,866 | I |
| MORSE DANIEL E. Director | 2018-02-28 | Sale | −7,000 | $0.79 | $5,530 | 14,866 | I |
| MORSE DANIEL E. Director | 2018-03-09 | Sale | −7,000 | $0.81 | $5,635 | 7,866 | I |
| MORSE DANIEL E. Director | 2018-03-12 | Sale | −3,500 | $0.80 | $2,790 | 4,366 | I |
| Derivatives | |||||||
| MORSE DANIEL E. Director | 2018-03-12 | Grant or award · Share Option (Right to Buy) | +2,500 | 2,500 | D | ||
| Open-market sales · 32,300 sh · avg $0.79 · $25,600 | |||||||
Loading xslF345X03/tv488572_4.xml…